Chemically defined sequential culture media for TH+ cell derivation from human embryonic stem cells

Molecular Human Reproduction

Volumn 14, Issue 11, 2008, Pages 619-625

  Song, Tianran ^a   Chen, Guian ^a   Wang, Yue ^b   Mao, Genhong ^a   Wang, Yanxia ^a   Bai, Haiyan ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Human embryonic stem cell; In vitro differentiation; TH positive cells; Transplantation

Indexed keywords

APOMORPHINE; BETA TUBULIN; BETA TUBULIN TYPE 3; DOPAMINE; DOPAMINE TRANSPORTER; NUCLEAR RECEPTOR RELATED FACTOR 1; POTASSIUM ION; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CHEMICAL MODIFICATION; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; CELL SHAPE; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; EMBRYONIC STEM CELLS; FEMALE; HUMANS; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 57649235915     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gan058     Document Type: Article

References (38)

1. Abbondanzo SJ, Gadi I, Stewart CL. Derivation of embryonic stem cell lines. Meth Enzymol 1993;225:803-823.
2. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962;138:360-375.
3. Arenas E. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 2002;57:795-808.
4. Branton RL, Love RM, Clarke DJ. cAMP included during cell suspension preparation improves survival of dopaminergic neurons in vitro. Neuroreport 1998;9:3223-3227.
5. Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006;24:1433-1440.
6. Brundin P. GDNF treatment in Parkinson's disease: Time for controlled clinical trials? Brain 2002;125:2149-2151.
7. Buytaert-Hoefen K, Alvarez E, Freed C. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 2004;22:669-674.
8. Clarkson ED, Zawada WM, Freed CR. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport 1995;7:145-149.
9. Dunnett SB, Bjorklund A, Lindvall O. Cell therapy in Parkinson's disease-stop or go? Nat Rev Neurosci 2001;2:365-369.
10. Flanders KC, Ren RF, Lippa CF. Transforming growth factors in neurodegenerative disease. Progr Neurobiol 1998;54:71-85.
11. Geeta R, Ramnath RL, Rao HS, Viswanathan C. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons. Biochem Biophys Res Commun 2008;373:258-264.
12. Hynes M, Rosenthal A. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 1999;9 26-36.
13. Iacovitti L, Donaldson AE, Marshall CE, Suon S, Yang M. A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res 2007;1127:19-25.
14. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28:31-40.
15. Kawasaki H, Suemori H, Mizuseki K, Watanabe K, Urano F, Ichinose H, Haruta M, Takahashi M, Yoshikawa K, Nishikawa S et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc Natl Acad Sci USA 2002;99: 1580-1585.
16. Krieglstein K, Henheik P, Farkas L, Jaszai J, Galter D, Krohn K, Unsicker K. Glial cell line-derived neurotrophic factor requires transforming growth factor-β for exerting its full neurotrophic potential on peripheral and CNS neurons. J Neurosci 1998;18 9822-9834.
17. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000;18:675-679.
18. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell linederived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-1132.
19. Luo Y, Schwartz C, Shin S, Zeng X, Chen N, Wang Y, Yu X, Rao MS. A focused microarray to assess dopaminergic and glial cell differentiation from fetal tissue or embryonic stem cells. Stem Cells 2006;24 865-875.
20. Park S, Lee KS, Lee YJ, Shin HA, Cho HY, Wang KC, Kim YS, Lee HT, Chung KS, Kim EY et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett 2004;359:99-103.
21. Park CH, Minn YK, Lee JY, Dong Ho Choi, Chang MY, Shim JW, Ko JY, Koh HC, Kang MJ, Kang JS et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J Neurochem 2005;92:1265-1276.
22. Peng HM, Chen GA. Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum Reprod 2006; 21:217-222.
23. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004;101:12543-12548.
24. Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 2001;105 93-104.
25. Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, Pensa KA, Meedeniya ACB, Davidson BP, Lambert NA, Condie BG et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 2004;22:1218-1238.
26. Sonntag KC, Simantov R, Isacson O. Stem cells may reshape the prospect of Parkinson's disease therapy. Mol Brain Res 2005;134:34-51.
27. Sonntag KC, Pruszak J, Yoshizaki T, Van Arensbergen J, Sanchez-Pernaute R, Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist Noggin. Stem Cells 2007; 25: 411-418.
28. Studer L, Psylla M, Buhler B, Evtouchenko L, Vouga CM, Leenders KL, Seiler RW, Spenger C. Noninvasive dopamine determination by reversed phase HPLC in the medium of free-floating roller tube cultures of rat fetal ventral mesencephalon: A tool to assess dopaminergic tissue prior to grafting. Brain Res Bull 1996;41:143-150.
29. Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 2005;115:102-109.
30. Taylor H, Minger SL. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells. Curr Opin Biotechnol 2005;16:487-492.
31. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
32. Vitalis T, Cases O, Parnavelas JG. Development of the dopaminergic neurons in the rodent brainstem. Exp Neurol 2005;191:104-112.
33. Widmer HR, Schaller B, Meyer M, Seiler RW. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindinand calretinin-expressing neurons. Exp Neurol 2000;164:71-81.
34. Yamazoe H, Iwata H. Effcient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers. Biomaterials 2006;27:4871-4880.
35. Yan Y, Yang D, Zarnowska ED, Du Z, Werbel B, Valliere C, Pearce RA, Thomson JA, Zhang SC. Directed differentiation of dopaminergic neuronal subtypes from human embryonic. Stem Cells 2005;23: 781-790.
36. Ye W, Shimamura K, Rubenstein JL, Hynes MA, Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998;93:755-766.
37. Yoshizaki T, Inaji M, Kouike H, Shimazaki T, Sawamoto K, Ando K, Date I, Kobayashi K, Suhara T, Uchiyama Y et al. Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells. Neurosci Lett 2004;363:33-37.
38. Zeng X, Cai J, Chen J, Luo Y, You ZB, Fotter E, Wang Y, Harvey B, Miura T, Backman C et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 2004;22:925-940.